The drug is not FDA approved, and the agency recommends that consumers using the product stop using it and consult their health care provider if they have experienced any adverse events that could be related to its use
Conclusion Semaglutide represents a significant advancement in the management of type 2 diabetes and obesity
Although its rare, some people have serious side effects, even suicidal thoughts as the medications often increase energy and motivation before they decrease depression.Most SSRIs need to be taken daily for 4-6 weeks to notice full effects, though many people notice improvements in symptoms in about 2 weeks
If your primary goal is weight management and you dont have diabetes, Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are the FDA-approved options
Sometimes, people need to slow down their dosing and stay at a lower dose for longer
Tirzepatide carries a boxed MTC warning and a characterised pancreatitis / gallbladder / hypersensitivity profile 28 29